Remembrance of JUDr. Eva Madajová
Published in:
Diab Obez 2023; 23(46): 133
Category:
Personal news
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2023 Issue 46
-
All articles in this issue
- Prevalence of obesity and type 2 diabetes mellitus
- Screening for diabetic retinopathy in diabetic outpatient clinics using arteficial intelligence: a pilot project of the Slovak Diabetes Society
- Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)
- Benefit of early treatment with dapagliflozin in primary prevention in patients with type 2 diabetes mellitus
- Cardio-renal and metabolic benefits of empagliflozin: additional indication and change in indication restrictions
- Obesity and heart failure with preserved ejection fraction – dapagliflozin also shows clinical benefit here
- The SGLT2 inhibitor canagliflozin: a comprehensive effect in the treatment of type 2 diabetes mellitus
- International Peace Marathon – try once, love forever!
- Summary of the 59th Annual Congress of the European Association for the Study of Diabetes
- MUDr. Martina Merčiaková, MBA – portrét ambulantnej diabetologičky
- MUDr. Ján Truban – portrét ambulantného diabetológa
- Remembrance of JUDr. Eva Madajová
- In memoriam MUDr. Evy Virčíkovej
- Diabetes and obesity
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Prevalence and mortality of patients with type 2 diabetes mellitus in 2010–2015 and mortality during the COVID pandemic (April 2020–March 2021)
- Prevalence of obesity and type 2 diabetes mellitus
- MUDr. Ján Truban – portrét ambulantného diabetológa
- Cardio-renal and metabolic benefits of empagliflozin: additional indication and change in indication restrictions